Szerman, Nestor http://orcid.org/0000-0002-9821-7958
Torrens, Marta
Maldonado, Rafael http://orcid.org/0000-0002-4359-8773
Balhara, Yatan Pal Singh
Salom, Caroline http://orcid.org/0000-0002-8986-9735
Maremmani, Icro
Sher, Leo
Didia-Attas, Javier
Chen, Jun http://orcid.org/0000-0002-3837-2761
Baler, Ruben http://orcid.org/0000-0002-0621-0346
,
Article History
Received: 6 May 2022
Revised: 22 September 2022
Accepted: 29 September 2022
First Online: 13 October 2022
Competing interests
: NS: has received honoraria/expenses from Lundbeck, Janssen, Takeda and Otsuka and fee for Consulting/ Advisory Board from Neuroxpharm. MT: has received honoraria or consultation fees for:Gilead, MSD, Camurus, Servier, Angellini, Lundbeck, Otzuka, and fee for participation in a company sponsored speaker’s bureau of Camurus, Servier, Angellini, Lundbeck, Otzuka. The remaining authors declare no competing interests.